Rugen Therapeutics
Boston, United States · Founded 2013 · $46.5M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Founded
- 2013
- Total Funding
- $46.5M
- Last Round
- $38.0M Series AJun 2020
- Rounds
- 2
About
Biotech company developing first-in-class small-molecule drugs for CNS disorders including autism, OCD, and treatment-resistant depression.
Summary
Rugen Therapeutics is a Biotech company based in Boston, United States, founded in 2013. It has raised $46.5M in total across 2 rounds, most recently a $38.0M Series A round in Jun 2020. Investors include F-Prime Capital and Boehringer Ingelheim Venture Fund.
Funding History
Jun 2020
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/rugen-therapeutics"><img src="https://indexed.vc/api/badge/company/rugen-therapeutics" alt="Rugen Therapeutics on Indexed.vc" width="260" height="76" /></a>